NW-101C

· Neowise Biotechnology

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NW-101C, covering 2025-12-12 to 2025-12-12. Get the full timeline:

Most recent: Clinical Trial Update: TCR-engineered T Cells (NW-101C) in Patients With Solid Malignant Tumors [Phase 1]